There is a significant number of new reports today, addressing such issues as: data from a large series of robotic prostatectomy patients; the importance of positive surgical margins and their management; the significance of number of positive lymph nodes in N+M0 patients; evolving models of the role of testosterone in prostate cancer progression; and data on the clinical use of the investigational LHRH antagonist degarelix. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: Degarelix, positive lymph nodes, robotic laparoscopic prostatectomy, surgical margins, testosterone | Leave a comment »
